These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22214714)

  • 1. Macro- and microrheological parameters of blood in patients with cerebral and peripheral atherosclerosis: the molecular change mechanisms after pentoxifylline treatment.
    Muravyov AV; Bulaeva SV; Tikhomirova IA; Zamishlayev AV; Uzikova EV; Miloradov MJ
    Clin Hemorheol Microcirc; 2011; 49(1-4):431-9. PubMed ID: 22214714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell aggregation changes are depended on its initial value: Effect of long-term drug treatment and short-term cell incubation with drug.
    Muravyov AV; Tikhomirova IA; Maimistova AA; Bulaeva SV; Mikhailov PV; Kislov NV
    Clin Hemorheol Microcirc; 2011; 48(4):231-40. PubMed ID: 22012828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra- and intracellular signaling pathways under red blood cell aggregation and deformability changes.
    Muravyov AV; Tikhomirova IA; Maimistova AA; Bulaeva SV
    Clin Hemorheol Microcirc; 2009; 43(3):223-32. PubMed ID: 19923692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: in vitro study.
    Muravyov AV; Yakusevich VV; Chuchkanov FA; Maimistova AA; Bulaeva SV; Zaitsev LG
    Clin Hemorheol Microcirc; 2007; 36(4):327-34. PubMed ID: 17502703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between adenylyl cyclase signaling pathway and Ca2+ regulatory mechanism under red blood cell microrheological changes.
    Muravyov AV; Tikhomirova IA; Maimistova AA; Bulaeva SV; Zamishlayev AV; Batalova EA
    Clin Hemorheol Microcirc; 2010; 45(2-4):337-45. PubMed ID: 20675917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficiency and hemorheological consequences of hemotransfusion and epoetin therapy in anemic cancer patients.
    Muravyov AV; Cheporov SV; Kislov NV; Bulaeva SV; Maimistova AA
    Clin Hemorheol Microcirc; 2010; 44(2):115-23. PubMed ID: 20203366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorheological changes in solid tumor patients after treatment with recombinant erythropoetin.
    Muravyov AV; Cheporov SV; Kislov NV; Volkova EL
    Clin Hemorheol Microcirc; 2009; 41(1):39-47. PubMed ID: 19136741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of diuretics on red blood cell microrheological parameters in female hypertensive patients.
    Muravyov AV; Yakusevich VV; Kabanov AV; Petrochenko AS
    Clin Hemorheol Microcirc; 2005; 33(2):121-6. PubMed ID: 16151259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of protein kinases of human red cell membrane in deformability and aggregation changes].
    Murav'ev AV; Maĭmistova AA; Tikhomirova IA; Bulaeva SV; Mikhaĭlov PV; Murav'ev AA
    Fiziol Cheloveka; 2012; 38(2):94-100. PubMed ID: 22679802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antioxidant properties of pentoxifylline and vinpocetine in a rheological model.
    Horvath B; Vekasi J; Kesmarky G; Toth K
    Clin Hemorheol Microcirc; 2008; 40(2):165-6. PubMed ID: 19029641
    [No Abstract]   [Full Text] [Related]  

  • 12. Role Ca(2+) in mechanisms of the red blood cells microrheological changes.
    Muravyov A; Tikhomirova I
    Adv Exp Med Biol; 2012; 740():1017-38. PubMed ID: 22453982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
    Szapáry L; Horváth B; Alexy T; Márton Z; Késmárky G; Szóts M; Nagy F; Czopf J; Tóth K
    Orv Hetil; 2003 May; 144(20):973-8. PubMed ID: 12830727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients.
    Muravyov AV; Yakusevich VV; Surovaya L; Petrochenko A
    Clin Hemorheol Microcirc; 2004; 31(4):251-6. PubMed ID: 15567894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel: hemorheological effects in subjects with subclinical atherosclerosis.
    Ciuffetti G; Lombardini R; Pirro M; Lupattelli G; Mannarino E
    Clin Hemorheol Microcirc; 2001; 25(1):31-9. PubMed ID: 11790868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids.
    Sinha B; Semmler J; Eisenhut T; Eigler A; Endres S
    Eur J Immunol; 1995 Jan; 25(1):147-53. PubMed ID: 7843225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effect of pentoxifylline and lisofylline on deformability and aggregation of red blood cells from healthy subjects and patients with chronic venous disease.
    Słoczyńska K; Kózka M; Pękala E; Marchewka A; Marona H
    Acta Biochim Pol; 2013; 60(1):129-35. PubMed ID: 23520579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemorheological, cardiorespiratory, and cerebrovascular effects of pentoxifylline following acclimatization to 3,800 m.
    Steele AR; Howe CA; Gibbons TD; Foster K; Williams AM; Caldwell HG; Brewster LM; Duffy J; Monteleone JA; Subedi P; Anholm JD; Stembridge M; Ainslie PN; Tremblay JC
    Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H705-H714. PubMed ID: 38241007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of vinpocetine, pentoxifylline and nicergoline on red blood cell deformability.
    Hayakawa M
    Arzneimittelforschung; 1992 Feb; 42(2):108-10. PubMed ID: 1610415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of antigen- and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors.
    Essayan DM; Huang SK; Undem BJ; Kagey-Sobotka A; Lichtenstein LM
    J Immunol; 1994 Oct; 153(8):3408-16. PubMed ID: 7930566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.